DcR1 抗体
(Tumor Necrosis Factor Receptor Superfamily, Member 10c (TNFRSF10C))
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL. [provided by RefSeq, Jul 2008].
recommended
recommended
recommended
DcR1 抗体 by 适用
Find DcR1 抗体 for a variety of species such as anti-Human DcR1, anti-Mouse DcR1, anti-Rat DcR1. The species listed below are among those available. Click on a link to go to the corresponding products.
DcR1 抗体 by 抗体来源
Find DcR1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
DcR1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal DcR1 抗体. Click on a link to go to the corresponding products.
DcR1 抗体 by 克隆
Find DcR1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular DcR1 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human, Rat
Application
WB, ELISA, IHC
Validations
- (3)
Cat. No.
ABIN6265636
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
FACS
Validations
- (3)
Cat. No.
ABIN301991
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Human
Application
FACS
Validations
- (2)
Cat. No.
ABIN6579816
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (2)
Cat. No.
ABIN3021518
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
FACS
Validations
- (2)
Cat. No.
ABIN457355
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Human
Application
FACS, IHC
Validations
- (2)
Cat. No.
ABIN1169229
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
FACS
Validations
- (2)
Cat. No.
ABIN457377
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p)
Validations
- (1)
Cat. No.
ABIN2173540
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
FACS, Func
Validations
- (1)
Cat. No.
ABIN1383916
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (1)
Cat. No.
ABIN1383734
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
FACS, ICC
Validations
- (5)
Cat. No.
ABIN1169230
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB
Validations
- (1)
Cat. No.
ABIN926878
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, IHC, ICC
Validations
- (2)
Cat. No.
ABIN5014477
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, ELISA, IF
Validations
- (2)
Cat. No.
ABIN1030838
Quantity
0.1 mg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, IF, EIA
Validations
- (2)
Cat. No.
ABIN499722
Quantity
0.1 mg
Datasheet
Datasheet
Latest Publications for our DcR1 抗体
: "Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells." in: PLoS ONE, Vol. 14, Issue 4, pp. e0214847, (2019) (PubMed).: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells." in: Frontiers in immunology, Vol. 10, pp. 2044, (2019) (PubMed).
: "Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells." in: Cell death & disease, Vol. 8, Issue 8, pp. e3025, (2018) (PubMed).
: "TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis." in: Scientific reports, Vol. 7, Issue 1, pp. 5514, (2017) (PubMed).
: "Targeting Apoptotic Activity Against Prostate Cancer Stem Cells." in: International journal of molecular sciences, Vol. 18, Issue 8, (2017) (PubMed).
: "The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2." in: Molecular cell, Vol. 65, Issue 4, pp. 730-742.e5, (2017) (PubMed).
: "Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma." in: Stem cells translational medicine, Vol. 3, Issue 2, pp. 172-82, (2014) (PubMed).
: "Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes." in: The Journal of biological chemistry, Vol. 289, Issue 23, pp. 16576-87, (2014) (PubMed).
: "TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells." in: Anticancer research, Vol. 34, Issue 2, pp. 729-34, (2014) (PubMed).
Aliases for DcR1 抗体
TNF receptor superfamily member 10c (TNFRSF10C) 抗体CD263 抗体
DCR1 抗体
DCR1-TNFR 抗体
LIT 抗体
TNFRSF10C 抗体
TRAIL-R3 抗体
TRAILR3 抗体
TRID 抗体
您还需要查找其他产品吗？
You are here:
